PCV-2 VACCINE IN MDA POSITIVE PIGLETS

摘要

The present invention relates to use of ORF-2 protein of porcine circovirus type 2 (PCV-2) for the manufacture of a vaccine comprising at least 20 microgram/dose of said ORF-2 protein and useful for the protection of piglets that are PCV-2 MDA positive against PCV-2 infection, wherein said vaccine comprises at least 20 micrograms/dose of ORF-2 protein of porcine circovirus type 2 (PCV-2) and a suitable adjuvant.